Doylestown Health: Taking Laboratory Testing In-House
While serving the region, Doylestown Health has a small clinical laboratory. To better serve its community, it added NGS in 2023.Â
While serving the region, Doylestown Health has a small clinical laboratory. To better serve its community, it added NGS in 2023.Â
Ambry Genetics unveiled a new multiomic exome sequencing test that incorporates RNA analysis to enhance the detection of rare diseases.
Jona announced a new distribution partnership where practitioners can order Jona kits, the company’s AI-powered gut microbiome profile test.
Findings from NGS suggest that revising cancer care guidelines could allow many more patients to benefit from immunotherapy treatment.
Read MoreGenomenon, a genomic intelligence company, has launched Genomenon Curate-Pro, a rapid on-demand...
Read MoreIllumina’s Global Health Access Initiative will support access to pathogen sequencing tools for public health in lower income countries.
Read MoreSequentify announced Stanford will be using the company’s NGS targeted panels for acute myeloid leukemia (AML) somatic mutation detection.
Read MoreCentogene announced the expansion of MOx, the company’s multiomic diagnostic portfolio, now incorporating transcriptomic analysis.
Read MoreThe new NGS test detects gene fusions, translocations, and rearrangements across 361 genes from FFPE tumor tissue.Â
Read MoreThe Jackson Lab for Genomic Medicine is offering a clinical whole genome sequencing test to improve the diagnostic power of sequencing.
Read MoreThe study sequenced the genomes of infants with seizures to understand the strengths of early, broad genome sequencing of infantile epilepsy.
Read MoreResearchers have created an AI-based tool that uses tumor gene sequencing data to predict the primary source of a patient’s cancer.
Read MoreNew Element Biosciences technology has helped identify the likely genetic causes of disorders in six of nine children from Sonora, Mexico.
Read MoreThe new DM-Seq technique allows for scientists to profile DNA using very small samples and without damaging the sample.
Read MoreThe noninvasive method diagnoses atopic dermatitis by analyzing RNA from samples of sebum collected from infants using an oil-blotting film.
Read MoreUsing a CRISPR-based depletion technology and NGS overcomes limitations by targeting and removing abundant host and microbial rRNA sequences, making NGS suitable for pandemic preparedness.
Read MoreThe study’s multi-cancer early detection data show Exai’s RNA- and AI-based platform can detect multiple cancer types at the earliest stages using a single, standard blood sample.
Read MoreMetagenomic sequencing offers actionable antimicrobial resistance predictions for bloodstream infections faster than conventional lab tests.
Read More